StreetInsider.com News Articles

Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Heino Mary Anne

Wed, 03 Jun 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260603/26599761.html

Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Heino Mary Anne

Wed, 03 Jun 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260603/26599761.html

Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Ber Gerard

Wed, 03 Jun 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260603/26599779.html

Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Ber Gerard

Wed, 03 Jun 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260603/26599779.html

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Wed, 03 Jun 2026 08:30:00 -0400

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins, Vice President, External Manufacturing, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9.

To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Wed, 03 Jun 2026 08:30:00 -0400

To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on

Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

Tue, 02 Jun 2026 08:00:00 -0400

BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that an image generated using LNTH-2513 (18F-GP1) PET/CT was awarded SNMMI’s Image of the Year at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting in Los Angeles, California. The recognition was presented in connection with investigator-initiated trial results evaluating LNTH-2513 PET/CT for the detection of acute lower-extremity deep vein thrombosis (DVT) in symptomatic patients.